

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89579486 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 4.85952737 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80621402 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.80621402 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.26829252 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.26829252 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17071115 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17071115 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.17071115 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17071115 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.17071115 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17071115 |
| 13 | detection of external biotic stimulus (GO:0098581) | 4.05881780 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.01948159 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.01948159 |
| 16 | detection of other organism (GO:0098543) | 4.00608679 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.89680891 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85267692 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.83923507 |
| 20 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.82846718 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.82617836 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.73119596 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.58910220 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.58018241 |
| 25 | detection of bacterium (GO:0016045) | 3.56405243 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52497592 |
| 27 | cysteine metabolic process (GO:0006534) | 3.52357761 |
| 28 | lysine catabolic process (GO:0006554) | 3.51926163 |
| 29 | lysine metabolic process (GO:0006553) | 3.51926163 |
| 30 | negative regulation of protein activation cascade (GO:2000258) | 3.51498367 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.51012769 |
| 32 | urea metabolic process (GO:0019627) | 3.49851633 |
| 33 | urea cycle (GO:0000050) | 3.49851633 |
| 34 | glutamate metabolic process (GO:0006536) | 3.46630368 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.45491391 |
| 36 | response to interleukin-15 (GO:0070672) | 3.44522697 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.44164250 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42497458 |
| 39 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.41260143 |
| 40 | negative regulation of complement activation (GO:0045916) | 3.38185260 |
| 41 | negative regulation of B cell mediated immunity (GO:0002713) | 3.34041586 |
| 42 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.34041586 |
| 43 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.33764073 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.31541018 |
| 45 | cellular extravasation (GO:0045123) | 3.31414047 |
| 46 | bile acid biosynthetic process (GO:0006699) | 3.31020038 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.29821420 |
| 48 | drug catabolic process (GO:0042737) | 3.26520731 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.25599728 |
| 50 | glyoxylate metabolic process (GO:0046487) | 3.21338825 |
| 51 | kynurenine metabolic process (GO:0070189) | 3.20723948 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20286047 |
| 53 | negative regulation of humoral immune response (GO:0002921) | 3.19359056 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.19022897 |
| 55 | locomotory exploration behavior (GO:0035641) | 3.16799704 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.14796538 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 3.13288426 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06005526 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05981335 |
| 60 | layer formation in cerebral cortex (GO:0021819) | 3.05378632 |
| 61 | synaptic vesicle maturation (GO:0016188) | 3.04519830 |
| 62 | negative regulation of type 2 immune response (GO:0002829) | 3.03811179 |
| 63 | protein carboxylation (GO:0018214) | 3.01347787 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.01347787 |
| 65 | nucleobase catabolic process (GO:0046113) | 2.98700514 |
| 66 | regulation of fibrinolysis (GO:0051917) | 2.98402981 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 2.98279193 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 2.98279193 |
| 69 | tryptophan catabolic process (GO:0006569) | 2.98279193 |
| 70 | microglial cell activation (GO:0001774) | 2.98029806 |
| 71 | glutamate secretion (GO:0014047) | 2.97441661 |
| 72 | response to host immune response (GO:0052572) | 2.97291175 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97291175 |
| 74 | complement activation, alternative pathway (GO:0006957) | 2.95860447 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.93234144 |
| 76 | regulation of beta-amyloid formation (GO:1902003) | 2.92564087 |
| 77 | homocysteine metabolic process (GO:0050667) | 2.91782475 |
| 78 | regulation of protein activation cascade (GO:2000257) | 2.91481114 |
| 79 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.91129129 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91087663 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89863708 |
| 82 | neutrophil mediated immunity (GO:0002446) | 2.87973726 |
| 83 | bile acid metabolic process (GO:0008206) | 2.87199080 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.86400932 |
| 85 | regulation of cellular amide metabolic process (GO:0034248) | 2.86152707 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.85452293 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.83487803 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83295514 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83241358 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 2.81350784 |
| 91 | macrophage activation (GO:0042116) | 2.80483630 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.79001238 |
| 93 | exogenous drug catabolic process (GO:0042738) | 2.78358077 |
| 94 | response to host (GO:0075136) | 2.76956309 |
| 95 | response to host defenses (GO:0052200) | 2.76956309 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76956309 |
| 97 | reverse cholesterol transport (GO:0043691) | 2.76256757 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76052653 |
| 99 | response to peptidoglycan (GO:0032494) | 2.75379391 |
| 100 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.74589054 |
| 101 | regulation of complement activation (GO:0030449) | 2.74242972 |
| 102 | triglyceride homeostasis (GO:0070328) | 2.73979483 |
| 103 | acylglycerol homeostasis (GO:0055090) | 2.73979483 |
| 104 | tyrosine metabolic process (GO:0006570) | 2.73764461 |
| 105 | vocalization behavior (GO:0071625) | 2.73465599 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 2.73292708 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 2.73140258 |
| 108 | negative regulation of sterol transport (GO:0032372) | 2.73140258 |
| 109 | proline transport (GO:0015824) | 2.72149010 |
| 110 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.72125294 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.71846958 |
| 112 | epoxygenase P450 pathway (GO:0019373) | 2.71106844 |
| 113 | ketone body metabolic process (GO:1902224) | 2.69307913 |
| 114 | neutrophil activation (GO:0042119) | 2.68475374 |
| 115 | regulation of ARF protein signal transduction (GO:0032012) | 2.66552476 |
| 116 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65525822 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 2.65307815 |
| 118 | alpha-amino acid catabolic process (GO:1901606) | 2.62700732 |
| 119 | coenzyme catabolic process (GO:0009109) | 2.62451625 |
| 120 | flavonoid metabolic process (GO:0009812) | 2.61011353 |
| 121 | aromatic amino acid family metabolic process (GO:0009072) | 2.60221072 |
| 122 | neurotransmitter secretion (GO:0007269) | 2.59442745 |
| 123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59143943 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 2.58480581 |
| 125 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56362695 |
| 126 | activation of protein kinase A activity (GO:0034199) | 2.56292535 |
| 127 | myeloid leukocyte mediated immunity (GO:0002444) | 2.55902825 |
| 128 | drug transmembrane transport (GO:0006855) | 2.55550338 |
| 129 | protein-lipid complex remodeling (GO:0034368) | 2.55220107 |
| 130 | macromolecular complex remodeling (GO:0034367) | 2.55220107 |
| 131 | plasma lipoprotein particle remodeling (GO:0034369) | 2.55220107 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 2.55180936 |
| 133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54257929 |
| 134 | aspartate family amino acid catabolic process (GO:0009068) | 2.53452914 |
| 135 | amino-acid betaine metabolic process (GO:0006577) | 2.53065567 |
| 136 | bile acid and bile salt transport (GO:0015721) | 2.52906151 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52847813 |
| 138 | alanine transport (GO:0032328) | 2.52704592 |
| 139 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.51326608 |
| 140 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.51326608 |
| 141 | 2-oxoglutarate metabolic process (GO:0006103) | 2.49390947 |
| 142 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.48196010 |
| 143 | acetyl-CoA metabolic process (GO:0006084) | 2.47793278 |
| 144 | regulation of bile acid biosynthetic process (GO:0070857) | 2.47736346 |
| 145 | fatty acid transmembrane transport (GO:1902001) | 2.47640454 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47347432 |
| 147 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.46706634 |
| 148 | dicarboxylic acid catabolic process (GO:0043649) | 2.46450556 |
| 149 | exploration behavior (GO:0035640) | 2.45785200 |
| 150 | alkaloid metabolic process (GO:0009820) | 2.44931468 |
| 151 | gamma-aminobutyric acid transport (GO:0015812) | 2.42963183 |
| 152 | cellular glucuronidation (GO:0052695) | 2.42024605 |
| 153 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.41648230 |
| 154 | leukocyte aggregation (GO:0070486) | 2.41194967 |
| 155 | cholesterol efflux (GO:0033344) | 2.40671033 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.40603910 |
| 157 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.40603910 |
| 158 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.39865430 |
| 159 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.38139701 |
| 160 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.37348587 |
| 161 | regulation of humoral immune response (GO:0002920) | 2.37124418 |
| 162 | indolalkylamine metabolic process (GO:0006586) | 2.36527527 |
| 163 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.35652926 |
| 164 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.35509354 |
| 165 | synaptic vesicle exocytosis (GO:0016079) | 2.34939271 |
| 166 | midgut development (GO:0007494) | 2.34613448 |
| 167 | plasma lipoprotein particle clearance (GO:0034381) | 2.34433966 |
| 168 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.34308187 |
| 169 | negative regulation of lipase activity (GO:0060192) | 2.34135582 |
| 170 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.33268408 |
| 171 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.33139808 |
| 172 | granulocyte activation (GO:0036230) | 2.32857882 |
| 173 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.30910937 |
| 174 | respiratory burst (GO:0045730) | 2.29747955 |
| 175 | hypotonic response (GO:0006971) | 2.28185070 |
| 176 | germinal center formation (GO:0002467) | 2.26801496 |
| 177 | plasma lipoprotein particle assembly (GO:0034377) | 2.24046841 |
| 178 | I-kappaB phosphorylation (GO:0007252) | 2.22896266 |
| 179 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.21267665 |
| 180 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.20971688 |
| 181 | iron ion import (GO:0097286) | 2.20385393 |
| 182 | B cell receptor signaling pathway (GO:0050853) | 2.19944549 |
| 183 | regulation of leukocyte degranulation (GO:0043300) | 2.19686962 |
| 184 | cellular response to type I interferon (GO:0071357) | 2.19456004 |
| 185 | type I interferon signaling pathway (GO:0060337) | 2.19456004 |
| 186 | activated T cell proliferation (GO:0050798) | 2.18696752 |
| 187 | response to type I interferon (GO:0034340) | 2.18688846 |
| 188 | regulation of macrophage cytokine production (GO:0010935) | 2.18587222 |
| 189 | negative regulation of interleukin-12 production (GO:0032695) | 2.18375881 |
| 190 | regulation of necroptotic process (GO:0060544) | 2.18020950 |
| 191 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.17952269 |
| 192 | regulation of mast cell degranulation (GO:0043304) | 2.16784002 |
| 193 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.16304715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25493096 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22814299 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.91366420 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87375079 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74069052 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54717506 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45535237 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.36684905 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26845127 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13482155 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08039290 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00097368 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98313604 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96110198 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94328702 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94134314 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93576102 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92423608 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91014538 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90607930 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85947016 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82371348 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.82024846 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79892056 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.78947265 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77686717 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77686717 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77031469 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74241320 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73845343 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.67219065 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62368753 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.60119232 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60019166 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59992846 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58491759 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58093851 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54517872 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53596474 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51503910 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51501852 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51360425 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51182586 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49786421 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48710195 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.47196546 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42714261 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40476007 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40367070 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37193942 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36670558 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35346581 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35221594 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34506950 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34495458 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33021978 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32935440 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32753632 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31811930 |
| 60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30881722 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30268246 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28409591 |
| 63 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28173961 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27432452 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26061041 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25263680 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25261948 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25215081 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25027490 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24821689 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23814926 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23476183 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21802075 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21348918 |
| 75 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20876751 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19816022 |
| 77 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19016104 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18956279 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17842064 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17716700 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17481956 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17093105 |
| 83 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.15910980 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15785199 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15611814 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14967905 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14726912 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14639012 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14445219 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14102832 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13897565 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13805693 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13653333 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12693629 |
| 95 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11590199 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10457342 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09865993 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08403724 |
| 99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07906647 |
| 100 | AR_19668381_ChIP-Seq_PC3_Human | 1.06901367 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06186483 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05317688 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04491638 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03728514 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03477264 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03461169 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03446012 |
| 108 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03379318 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02691884 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02608653 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01890108 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01389818 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01267328 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01230543 |
| 115 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01083239 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00825664 |
| 117 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00235165 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98781601 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98402561 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98344102 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98228021 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97594671 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97594671 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97064702 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97002681 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96139236 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95159087 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94990219 |
| 129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93449412 |
| 130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93043487 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92610272 |
| 132 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91581378 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91476619 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91169740 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89414562 |
| 136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89198713 |
| 137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88407433 |
| 138 | MAF_26560356_Chip-Seq_TH1_Human | 0.88384372 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88185076 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87805901 |
| 141 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87616792 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87529060 |
| 143 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86963009 |
| 144 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86677952 |
| 145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85862834 |
| 146 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85506049 |
| 147 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.85326558 |
| 148 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84880260 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84867004 |
| 150 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84744905 |
| 151 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84411677 |
| 152 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84287485 |
| 153 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84110092 |
| 154 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83996689 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83540080 |
| 156 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83211914 |
| 157 | MYB_26560356_Chip-Seq_TH2_Human | 0.82119843 |
| 158 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81935222 |
| 159 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81593671 |
| 160 | MYB_26560356_Chip-Seq_TH1_Human | 0.80994138 |
| 161 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80919992 |
| 162 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80611667 |
| 163 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76951091 |
| 164 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75706358 |
| 165 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75172328 |
| 166 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74875850 |
| 167 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74195191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.58509634 |
| 2 | MP0005360_urolithiasis | 5.50457877 |
| 3 | MP0003724_increased_susceptibility_to | 5.20597603 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.10841904 |
| 5 | MP0005365_abnormal_bile_salt | 3.72954276 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.58044632 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.22179643 |
| 8 | MP0003436_decreased_susceptibility_to | 2.98325096 |
| 9 | MP0003252_abnormal_bile_duct | 2.96965318 |
| 10 | MP0003303_peritoneal_inflammation | 2.96636809 |
| 11 | MP0002132_abnormal_respiratory_system | 2.65762340 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.59548940 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.53715862 |
| 14 | MP0005451_abnormal_body_composition | 2.53630765 |
| 15 | MP0005409_darkened_coat_color | 2.51078904 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.47553098 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.43329771 |
| 18 | MP0004883_abnormal_blood_vessel | 2.22059305 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.20643061 |
| 20 | MP0008260_abnormal_autophagy | 2.07456329 |
| 21 | MP0004270_analgesia | 2.06111208 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.02516418 |
| 23 | MP0002419_abnormal_innate_immunity | 1.99941127 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.97030770 |
| 25 | MP0002009_preneoplasia | 1.85300638 |
| 26 | MP0002822_catalepsy | 1.85290763 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.84090603 |
| 28 | MP0003828_pulmonary_edema | 1.79286405 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.72819740 |
| 30 | MP0005332_abnormal_amino_acid | 1.72151816 |
| 31 | MP0005025_abnormal_response_to | 1.69374742 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.68976957 |
| 33 | MP0005083_abnormal_biliary_tract | 1.67899508 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.66226820 |
| 35 | MP0005164_abnormal_response_to | 1.65368700 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.61022808 |
| 37 | MP0003329_amyloid_beta_deposits | 1.59138628 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.55513918 |
| 39 | MP0009785_altered_susceptibility_to | 1.54154748 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.53504511 |
| 41 | MP0009745_abnormal_behavioral_response | 1.53124989 |
| 42 | MP0004130_abnormal_muscle_cell | 1.52133583 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.50136026 |
| 44 | MP0001851_eye_inflammation | 1.50014464 |
| 45 | MP0003868_abnormal_feces_composition | 1.48284894 |
| 46 | MP0006082_CNS_inflammation | 1.45670446 |
| 47 | MP0003880_abnormal_central_pattern | 1.45166574 |
| 48 | MP0003866_abnormal_defecation | 1.43419015 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.36323947 |
| 50 | MP0001800_abnormal_humoral_immune | 1.35822871 |
| 51 | MP0001958_emphysema | 1.32441962 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.30641693 |
| 53 | MP0002064_seizures | 1.27735510 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.27091223 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.26924806 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.25668942 |
| 57 | MP0000920_abnormal_myelination | 1.24361558 |
| 58 | MP0004484_altered_response_of | 1.22674172 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.21357639 |
| 60 | MP0003195_calcinosis | 1.20278336 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.17850547 |
| 62 | MP0002723_abnormal_immune_serum | 1.17608181 |
| 63 | MP0004858_abnormal_nervous_system | 1.16477162 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.16348909 |
| 65 | MP0005535_abnormal_body_temperature | 1.16274877 |
| 66 | MP0009840_abnormal_foam_cell | 1.13825053 |
| 67 | MP0005187_abnormal_penis_morphology | 1.13589847 |
| 68 | MP0001440_abnormal_grooming_behavior | 1.13458407 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.13328351 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.12689427 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.12494632 |
| 72 | MP0009046_muscle_twitch | 1.11506019 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.11010746 |
| 74 | MP0001790_abnormal_immune_system | 1.10032397 |
| 75 | MP0005387_immune_system_phenotype | 1.10032397 |
| 76 | MP0003075_altered_response_to | 1.08204226 |
| 77 | MP0001915_intracranial_hemorrhage | 1.07865605 |
| 78 | MP0000609_abnormal_liver_physiology | 1.07852141 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.07839741 |
| 80 | MP0001819_abnormal_immune_cell | 1.07771699 |
| 81 | MP0008004_abnormal_stomach_pH | 1.07765434 |
| 82 | MP0001968_abnormal_touch/_nociception | 1.06937310 |
| 83 | MP0000013_abnormal_adipose_tissue | 1.06859348 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.06039053 |
| 85 | MP0002396_abnormal_hematopoietic_system | 1.05918321 |
| 86 | MP0002166_altered_tumor_susceptibility | 1.05621479 |
| 87 | MP0000685_abnormal_immune_system | 1.05007966 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04311462 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 1.04185970 |
| 90 | MP0001486_abnormal_startle_reflex | 1.02144448 |
| 91 | MP0004947_skin_inflammation | 1.01775957 |
| 92 | MP0000604_amyloidosis | 1.01773990 |
| 93 | MP0004381_abnormal_hair_follicle | 1.00441420 |
| 94 | MP0002405_respiratory_system_inflammati | 0.99465462 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.98312299 |
| 96 | MP0006054_spinal_hemorrhage | 0.97018914 |
| 97 | MP0002133_abnormal_respiratory_system | 0.96980030 |
| 98 | MP0005388_respiratory_system_phenotype | 0.96980030 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.96540054 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.96206254 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96074522 |
| 102 | MP0003122_maternal_imprinting | 0.94579843 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.94388938 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.93203167 |
| 105 | MP0005166_decreased_susceptibility_to | 0.93158288 |
| 106 | MP0004885_abnormal_endolymph | 0.93066426 |
| 107 | MP0003806_abnormal_nucleotide_metabolis | 0.92392943 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.91518692 |
| 109 | MP0008469_abnormal_protein_level | 0.90276716 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.89476605 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.89270230 |
| 112 | MP0004924_abnormal_behavior | 0.89270230 |
| 113 | MP0003045_fibrosis | 0.89166338 |
| 114 | MP0002928_abnormal_bile_duct | 0.89099929 |
| 115 | MP0003632_abnormal_nervous_system | 0.88464127 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.88177735 |
| 117 | MP0002971_abnormal_brown_adipose | 0.87428561 |
| 118 | MP0008569_lethality_at_weaning | 0.87281116 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.87253883 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.87069718 |
| 121 | MP0001188_hyperpigmentation | 0.86911532 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.86368071 |
| 123 | MP0000751_myopathy | 0.85598401 |
| 124 | MP0000858_altered_metastatic_potential | 0.85487617 |
| 125 | MP0004043_abnormal_pH_regulation | 0.84572111 |
| 126 | MP0002272_abnormal_nervous_system | 0.83778872 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.83413845 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.83413845 |
| 129 | MP0000778_abnormal_nervous_system | 0.82365911 |
| 130 | MP0000569_abnormal_digit_pigmentation | 0.81562534 |
| 131 | MP0003633_abnormal_nervous_system | 0.81543244 |
| 132 | MP0000249_abnormal_blood_vessel | 0.80286331 |
| 133 | MP0003091_abnormal_cell_migration | 0.79683069 |
| 134 | MP0009053_abnormal_anal_canal | 0.79627528 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.79391378 |
| 136 | MP0004510_myositis | 0.79006731 |
| 137 | MP0001177_atelectasis | 0.78947847 |
| 138 | MP0004811_abnormal_neuron_physiology | 0.78497566 |
| 139 | MP0002557_abnormal_social/conspecific_i | 0.78100421 |
| 140 | MP0009764_decreased_sensitivity_to | 0.77045342 |
| 141 | MP0005448_abnormal_energy_balance | 0.75711963 |
| 142 | MP0003283_abnormal_digestive_organ | 0.75491061 |
| 143 | MP0000716_abnormal_immune_system | 0.75431240 |
| 144 | MP0000537_abnormal_urethra_morphology | 0.75307048 |
| 145 | MP0009115_abnormal_fat_cell | 0.74762183 |
| 146 | MP0008438_abnormal_cutaneous_collagen | 0.73392099 |
| 147 | MP0002398_abnormal_bone_marrow | 0.72995215 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.71729920 |
| 149 | MP0002067_abnormal_sensory_capabilities | 0.71322991 |
| 150 | MP0005376_homeostasis/metabolism_phenot | 0.71033305 |
| 151 | MP0008874_decreased_physiological_sensi | 0.70862769 |
| 152 | MP0004185_abnormal_adipocyte_glucose | 0.70255602 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.68071030 |
| 154 | MP0005423_abnormal_somatic_nervous | 0.67498992 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.66904029 |
| 156 | MP0002069_abnormal_eating/drinking_beha | 0.66719208 |
| 157 | MP0004085_abnormal_heartbeat | 0.66270189 |
| 158 | MP0002066_abnormal_motor_capabilities/c | 0.65864050 |
| 159 | MP0004272_abnormal_basement_membrane | 0.65592715 |
| 160 | MP0008872_abnormal_physiological_respon | 0.64980492 |
| 161 | MP0000955_abnormal_spinal_cord | 0.64383248 |
| 162 | MP0005334_abnormal_fat_pad | 0.63616903 |
| 163 | MP0000639_abnormal_adrenal_gland | 0.63536438 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.63385029 |
| 165 | MP0003690_abnormal_glial_cell | 0.63040073 |
| 166 | MP0002184_abnormal_innervation | 0.63004665 |
| 167 | MP0005084_abnormal_gallbladder_morpholo | 0.61472778 |
| 168 | MP0009643_abnormal_urine_homeostasis | 0.60991537 |
| 169 | MP0003631_nervous_system_phenotype | 0.60326842 |
| 170 | MP0003953_abnormal_hormone_level | 0.58801450 |
| 171 | MP0000230_abnormal_systemic_arterial | 0.58634742 |
| 172 | MP0001970_abnormal_pain_threshold | 0.58570205 |
| 173 | MP0005646_abnormal_pituitary_gland | 0.58258134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.28839927 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.66757279 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.37704970 |
| 4 | Peritonitis (HP:0002586) | 4.30273783 |
| 5 | Orchitis (HP:0100796) | 4.22410405 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.10435976 |
| 7 | Myositis (HP:0100614) | 4.03359521 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 3.92831702 |
| 9 | Optic neuritis (HP:0100653) | 3.92238726 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.92238726 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.74163803 |
| 12 | Gingival bleeding (HP:0000225) | 3.72892109 |
| 13 | Xanthomatosis (HP:0000991) | 3.69320815 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.60953620 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.52404798 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.52382666 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.50415760 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.43453649 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 3.17195978 |
| 20 | Ketosis (HP:0001946) | 3.12129507 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.11302925 |
| 22 | Complement deficiency (HP:0004431) | 3.05795926 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.04921214 |
| 24 | Epidermoid cyst (HP:0200040) | 3.02847443 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.01204704 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 2.95368047 |
| 27 | Ketoacidosis (HP:0001993) | 2.91199664 |
| 28 | Pulmonary embolism (HP:0002204) | 2.89258454 |
| 29 | Myokymia (HP:0002411) | 2.87661816 |
| 30 | Gingivitis (HP:0000230) | 2.82877741 |
| 31 | Amyloidosis (HP:0011034) | 2.82514614 |
| 32 | Hypolipoproteinemia (HP:0010981) | 2.76207958 |
| 33 | Hypochromic anemia (HP:0001931) | 2.72059734 |
| 34 | Hyperglycinemia (HP:0002154) | 2.70829742 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 2.68896315 |
| 36 | Subacute progressive viral hepatitis (HP:0006572) | 2.66823015 |
| 37 | Joint hemorrhage (HP:0005261) | 2.66778664 |
| 38 | Focal motor seizures (HP:0011153) | 2.63746821 |
| 39 | Hyperammonemia (HP:0001987) | 2.63511526 |
| 40 | Gout (HP:0001997) | 2.61910353 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.60341412 |
| 42 | Abnormality of the peritoneum (HP:0002585) | 2.59445224 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.58985044 |
| 44 | Hyperglycinuria (HP:0003108) | 2.58390617 |
| 45 | Polycythemia (HP:0001901) | 2.56239315 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.55866780 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.55183201 |
| 48 | Episodic fever (HP:0001954) | 2.53862802 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.53267082 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.53267082 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.52971192 |
| 52 | Keratoconjunctivitis (HP:0001096) | 2.52032383 |
| 53 | Focal seizures (HP:0007359) | 2.51554712 |
| 54 | Insidious onset (HP:0003587) | 2.49821602 |
| 55 | Termporal pattern (HP:0011008) | 2.49821602 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48909450 |
| 57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46430286 |
| 58 | Visual hallucinations (HP:0002367) | 2.45813671 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.44503044 |
| 60 | Status epilepticus (HP:0002133) | 2.41783611 |
| 61 | Action tremor (HP:0002345) | 2.40397035 |
| 62 | Arterial thrombosis (HP:0004420) | 2.38273776 |
| 63 | Skin nodule (HP:0200036) | 2.35792907 |
| 64 | Recurrent skin infections (HP:0001581) | 2.35449191 |
| 65 | Epistaxis (HP:0000421) | 2.34352976 |
| 66 | Hypoglycemic coma (HP:0001325) | 2.27360453 |
| 67 | Thrombophlebitis (HP:0004418) | 2.25273016 |
| 68 | Back pain (HP:0003418) | 2.24958242 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.23247437 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20382273 |
| 71 | Osteomalacia (HP:0002749) | 2.20366912 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19400154 |
| 73 | Hypercholesterolemia (HP:0003124) | 2.19290786 |
| 74 | Lymphangioma (HP:0100764) | 2.17568213 |
| 75 | Obstructive lung disease (HP:0006536) | 2.16983098 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16983098 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.16380077 |
| 78 | Urticaria (HP:0001025) | 2.14311205 |
| 79 | Cholecystitis (HP:0001082) | 2.14034382 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.14034382 |
| 81 | Glomerulonephritis (HP:0000099) | 2.13940674 |
| 82 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12576174 |
| 83 | Difficulty running (HP:0009046) | 2.12502590 |
| 84 | Abnormal social behavior (HP:0012433) | 2.10159110 |
| 85 | Impaired social interactions (HP:0000735) | 2.10159110 |
| 86 | Meningitis (HP:0001287) | 2.09783668 |
| 87 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08812884 |
| 88 | Encephalitis (HP:0002383) | 2.08439338 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.08391275 |
| 90 | Increased IgE level (HP:0003212) | 2.08355345 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.07141526 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.07062182 |
| 93 | Turricephaly (HP:0000262) | 2.06201847 |
| 94 | Neonatal onset (HP:0003623) | 2.05502140 |
| 95 | Thickened calvaria (HP:0002684) | 2.05463917 |
| 96 | Torticollis (HP:0000473) | 2.05384847 |
| 97 | Vasculitis (HP:0002633) | 2.05372405 |
| 98 | Muscle fiber splitting (HP:0003555) | 2.04606926 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.01954326 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 2.01618734 |
| 101 | Hyperventilation (HP:0002883) | 2.00104673 |
| 102 | Absence seizures (HP:0002121) | 1.99860028 |
| 103 | Chest pain (HP:0100749) | 1.99449452 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 1.99154874 |
| 105 | Metaphyseal cupping (HP:0003021) | 1.98903191 |
| 106 | Malnutrition (HP:0004395) | 1.97652375 |
| 107 | Fat malabsorption (HP:0002630) | 1.97337110 |
| 108 | Arterial tortuosity (HP:0005116) | 1.96900548 |
| 109 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96665957 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96271360 |
| 111 | Microcytic anemia (HP:0001935) | 1.95417365 |
| 112 | Cellulitis (HP:0100658) | 1.95167500 |
| 113 | Spontaneous abortion (HP:0005268) | 1.95043505 |
| 114 | Vascular tortuosity (HP:0004948) | 1.94501897 |
| 115 | Macroorchidism (HP:0000053) | 1.94170382 |
| 116 | Subaortic stenosis (HP:0001682) | 1.93732354 |
| 117 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.93732354 |
| 118 | Enlarged penis (HP:0000040) | 1.93047641 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.92557180 |
| 120 | Mitral stenosis (HP:0001718) | 1.91909853 |
| 121 | Spastic diplegia (HP:0001264) | 1.89438062 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.89301619 |
| 123 | Hepatocellular carcinoma (HP:0001402) | 1.88641382 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86529565 |
| 125 | Papilledema (HP:0001085) | 1.86490495 |
| 126 | Buphthalmos (HP:0000557) | 1.84985405 |
| 127 | Anorexia (HP:0002039) | 1.84423387 |
| 128 | Delayed CNS myelination (HP:0002188) | 1.83960507 |
| 129 | Abnormality of complement system (HP:0005339) | 1.83393274 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.83091217 |
| 131 | Hemoptysis (HP:0002105) | 1.82963053 |
| 132 | Obstructive sleep apnea (HP:0002870) | 1.82881760 |
| 133 | Focal dystonia (HP:0004373) | 1.82811156 |
| 134 | Hyperglycemia (HP:0003074) | 1.82791247 |
| 135 | Menorrhagia (HP:0000132) | 1.82721315 |
| 136 | Dilatation of the ascending aorta (HP:0005111) | 1.82355813 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.81916337 |
| 138 | Purpura (HP:0000979) | 1.81239805 |
| 139 | Urinary urgency (HP:0000012) | 1.81231365 |
| 140 | Postural instability (HP:0002172) | 1.80932210 |
| 141 | Craniofacial dystonia (HP:0012179) | 1.80756595 |
| 142 | Atonic seizures (HP:0010819) | 1.80458236 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.78526536 |
| 144 | Acanthocytosis (HP:0001927) | 1.78197537 |
| 145 | Agitation (HP:0000713) | 1.77840629 |
| 146 | Hepatoblastoma (HP:0002884) | 1.77614755 |
| 147 | Hypoglycemic seizures (HP:0002173) | 1.77479907 |
| 148 | Abnormality of proline metabolism (HP:0010907) | 1.75868489 |
| 149 | Hydroxyprolinuria (HP:0003080) | 1.75868489 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.75717540 |
| 151 | Acute hepatic failure (HP:0006554) | 1.75521567 |
| 152 | Bronchomalacia (HP:0002780) | 1.75378869 |
| 153 | Abnormality of the endocardium (HP:0004306) | 1.75374499 |
| 154 | Genetic anticipation (HP:0003743) | 1.75135994 |
| 155 | Viral hepatitis (HP:0006562) | 1.74534593 |
| 156 | Excessive salivation (HP:0003781) | 1.74495438 |
| 157 | Drooling (HP:0002307) | 1.74495438 |
| 158 | Anxiety (HP:0000739) | 1.73354482 |
| 159 | Dysdiadochokinesis (HP:0002075) | 1.72779389 |
| 160 | Gangrene (HP:0100758) | 1.71605283 |
| 161 | Poor eye contact (HP:0000817) | 1.69128863 |
| 162 | Depression (HP:0000716) | 1.68988689 |
| 163 | Aortic aneurysm (HP:0004942) | 1.68248423 |
| 164 | Onion bulb formation (HP:0003383) | 1.67198408 |
| 165 | Arthropathy (HP:0003040) | 1.66896773 |
| 166 | Toxemia of pregnancy (HP:0100603) | 1.66670093 |
| 167 | Lower limb asymmetry (HP:0100559) | 1.66525740 |
| 168 | Progressive cerebellar ataxia (HP:0002073) | 1.66435094 |
| 169 | Hyperuricemia (HP:0002149) | 1.66265084 |
| 170 | Increased purine levels (HP:0004368) | 1.66265084 |
| 171 | Stomatitis (HP:0010280) | 1.65659965 |
| 172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.65178632 |
| 173 | Supranuclear gaze palsy (HP:0000605) | 1.64207556 |
| 174 | Stomach cancer (HP:0012126) | 1.63326654 |
| 175 | Dysmetric saccades (HP:0000641) | 1.62869463 |
| 176 | Flat acetabular roof (HP:0003180) | 1.62844373 |
| 177 | Abnormal eating behavior (HP:0100738) | 1.62528536 |
| 178 | Long toe (HP:0010511) | 1.62278854 |
| 179 | Global brain atrophy (HP:0002283) | 1.62135997 |
| 180 | Ankle clonus (HP:0011448) | 1.61800743 |
| 181 | Hamartoma of the eye (HP:0010568) | 1.61751902 |
| 182 | Cortical dysplasia (HP:0002539) | 1.61750204 |
| 183 | Potter facies (HP:0002009) | 1.60997308 |
| 184 | Acne (HP:0001061) | 1.58941724 |
| 185 | Striae distensae (HP:0001065) | 1.58358271 |
| 186 | Thin bony cortex (HP:0002753) | 1.58267291 |
| 187 | Periodontitis (HP:0000704) | 1.57969311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.44429532 |
| 2 | MAP3K9 | 3.29129500 |
| 3 | NTRK3 | 3.05598136 |
| 4 | PKN2 | 3.00991961 |
| 5 | TRIB3 | 2.99985994 |
| 6 | EPHA4 | 2.46835195 |
| 7 | MAP2K3 | 2.44554714 |
| 8 | MAP3K4 | 2.34110382 |
| 9 | MAP2K4 | 2.33283192 |
| 10 | MARK1 | 2.27389647 |
| 11 | KSR2 | 2.19102404 |
| 12 | PRPF4B | 2.17198836 |
| 13 | TYK2 | 2.16775593 |
| 14 | FGFR3 | 2.09342214 |
| 15 | EPHB1 | 2.05211481 |
| 16 | LATS1 | 2.04679547 |
| 17 | LATS2 | 2.03187520 |
| 18 | YES1 | 2.02682631 |
| 19 | IRAK4 | 1.97244228 |
| 20 | PRKD3 | 1.96649839 |
| 21 | CSK | 1.90669921 |
| 22 | DAPK2 | 1.75928652 |
| 23 | MAP3K2 | 1.71744685 |
| 24 | MINK1 | 1.70720346 |
| 25 | BLK | 1.69565690 |
| 26 | AKT3 | 1.65453412 |
| 27 | STK38 | 1.63527729 |
| 28 | FRK | 1.63269356 |
| 29 | SIK1 | 1.61929746 |
| 30 | RET | 1.58476716 |
| 31 | NTRK1 | 1.58089881 |
| 32 | JAK2 | 1.57398699 |
| 33 | PAK6 | 1.56112957 |
| 34 | GRK6 | 1.54878111 |
| 35 | RIPK1 | 1.47028276 |
| 36 | CAMKK1 | 1.45905741 |
| 37 | FES | 1.43456762 |
| 38 | MAP2K7 | 1.40057716 |
| 39 | DYRK1B | 1.37540447 |
| 40 | KSR1 | 1.36708336 |
| 41 | ZAP70 | 1.29340938 |
| 42 | JAK1 | 1.27322429 |
| 43 | PDGFRA | 1.26907697 |
| 44 | MARK2 | 1.26156401 |
| 45 | NTRK2 | 1.25759702 |
| 46 | TYRO3 | 1.24153240 |
| 47 | PTK6 | 1.23400309 |
| 48 | MAP3K3 | 1.23252336 |
| 49 | LMTK2 | 1.22497457 |
| 50 | HCK | 1.21918565 |
| 51 | PAK3 | 1.17293372 |
| 52 | FGFR2 | 1.17168555 |
| 53 | MAP3K13 | 1.15826269 |
| 54 | EPHA3 | 1.15283780 |
| 55 | TNK2 | 1.11393019 |
| 56 | DDR2 | 1.11057453 |
| 57 | PDK4 | 1.07341179 |
| 58 | PDK3 | 1.07341179 |
| 59 | MAP3K7 | 1.06542930 |
| 60 | BCKDK | 1.04450625 |
| 61 | CAMK1G | 1.00576396 |
| 62 | FGR | 1.00135713 |
| 63 | PHKG2 | 1.00016103 |
| 64 | PHKG1 | 1.00016103 |
| 65 | FER | 0.99943810 |
| 66 | INSRR | 0.99722753 |
| 67 | JAK3 | 0.94694981 |
| 68 | MAP3K11 | 0.92762679 |
| 69 | CDK5 | 0.91711873 |
| 70 | IRAK2 | 0.91296558 |
| 71 | SGK3 | 0.89890489 |
| 72 | CAMKK2 | 0.89205335 |
| 73 | PTK2 | 0.88933815 |
| 74 | RAF1 | 0.88813960 |
| 75 | TAOK1 | 0.88218498 |
| 76 | PIK3CG | 0.84892490 |
| 77 | WNK4 | 0.84808126 |
| 78 | ERBB4 | 0.84317843 |
| 79 | CDK12 | 0.82156901 |
| 80 | MAP3K5 | 0.81558519 |
| 81 | CSNK1G2 | 0.81387178 |
| 82 | STK11 | 0.81342663 |
| 83 | TAOK3 | 0.81265881 |
| 84 | MST1R | 0.80931454 |
| 85 | NLK | 0.80109592 |
| 86 | FGFR4 | 0.79718810 |
| 87 | IRAK1 | 0.76437241 |
| 88 | EPHB2 | 0.75513233 |
| 89 | CDK19 | 0.74866662 |
| 90 | PRKCH | 0.74806074 |
| 91 | MAP2K1 | 0.74587837 |
| 92 | SIK2 | 0.74318193 |
| 93 | SGK223 | 0.73526344 |
| 94 | SGK494 | 0.73526344 |
| 95 | PRKCZ | 0.72408942 |
| 96 | MAP3K14 | 0.72331794 |
| 97 | WNK3 | 0.71776660 |
| 98 | MAP4K1 | 0.71268756 |
| 99 | HIPK2 | 0.71114440 |
| 100 | GRK5 | 0.71043251 |
| 101 | PDPK1 | 0.70667845 |
| 102 | MAPK12 | 0.70615108 |
| 103 | SGK2 | 0.69530858 |
| 104 | PRKCG | 0.67810680 |
| 105 | BTK | 0.66896807 |
| 106 | MAP3K1 | 0.66778123 |
| 107 | IKBKE | 0.66243889 |
| 108 | DYRK1A | 0.65971572 |
| 109 | SYK | 0.65874292 |
| 110 | MAP3K6 | 0.65839576 |
| 111 | FYN | 0.65036580 |
| 112 | ICK | 0.65034295 |
| 113 | NEK1 | 0.63718527 |
| 114 | PDK1 | 0.63400116 |
| 115 | PRKD2 | 0.62998837 |
| 116 | CASK | 0.62950330 |
| 117 | LYN | 0.62594089 |
| 118 | PRKAA1 | 0.61675785 |
| 119 | CAMK1D | 0.61353950 |
| 120 | FGFR1 | 0.60994442 |
| 121 | PLK2 | 0.60311612 |
| 122 | CAMK2A | 0.60146489 |
| 123 | TGFBR2 | 0.60106355 |
| 124 | STK24 | 0.59967941 |
| 125 | MOS | 0.58488782 |
| 126 | SIK3 | 0.58084957 |
| 127 | STK3 | 0.57135270 |
| 128 | CAMK4 | 0.56612077 |
| 129 | SGK1 | 0.55360222 |
| 130 | PNCK | 0.54625678 |
| 131 | PTK2B | 0.53879927 |
| 132 | NEK6 | 0.52583271 |
| 133 | ERBB2 | 0.52131868 |
| 134 | DMPK | 0.51901360 |
| 135 | LCK | 0.51549732 |
| 136 | CDK6 | 0.50992156 |
| 137 | MATK | 0.50590636 |
| 138 | BRD4 | 0.49986723 |
| 139 | WNK1 | 0.49348124 |
| 140 | ERN1 | 0.48871194 |
| 141 | RPS6KA3 | 0.47719817 |
| 142 | ALK | 0.46713244 |
| 143 | BMX | 0.46551123 |
| 144 | MAPK7 | 0.46442228 |
| 145 | PRKAA2 | 0.46163483 |
| 146 | NEK9 | 0.46061592 |
| 147 | BMPR2 | 0.44547253 |
| 148 | STK38L | 0.44266517 |
| 149 | MAP3K12 | 0.44192847 |
| 150 | PDGFRB | 0.44181582 |
| 151 | SCYL2 | 0.43757229 |
| 152 | CDK14 | 0.43000840 |
| 153 | ROCK1 | 0.42273723 |
| 154 | DAPK1 | 0.41798882 |
| 155 | UHMK1 | 0.41647937 |
| 156 | CSNK1G1 | 0.41153201 |
| 157 | PINK1 | 0.40274875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.92084662 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84474414 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73325950 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56139970 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11798240 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09180679 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91204001 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88799807 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84419078 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.83393045 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.81702756 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78802504 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75972154 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71763232 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68115675 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67367518 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57710486 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56401996 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53324423 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51962241 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47899556 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47379797 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41081228 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38598889 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37439529 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35028458 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33614646 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31021209 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30470887 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21001590 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17075475 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.16344639 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.15772320 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15469419 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15165604 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14542673 |
| 37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14492549 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11857566 |
| 39 | GABAergic synapse_Homo sapiens_hsa04727 | 1.11587449 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11124661 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10307893 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09434573 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09223850 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.08349325 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08191665 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07802189 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05916915 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04984718 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04779418 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02705434 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02262910 |
| 52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01244176 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01171698 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01140876 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99884503 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.99538825 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99474799 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.99142211 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98907546 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98425297 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97708327 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96928615 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96869754 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96686744 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.96143344 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95091897 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94617158 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.93666861 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91952067 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91895369 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91548137 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90087723 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90037951 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.89547206 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89110785 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88687293 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87005211 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86979738 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86886322 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.86235656 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86174576 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.86151977 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85773209 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85527275 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85296552 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.85092999 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83576667 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.83503762 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.83389239 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82080593 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81860634 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81320750 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81068133 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80676985 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80512216 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79658988 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78481183 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78358522 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77646505 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76243278 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.76136076 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.75242597 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72626818 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72489622 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71703200 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71309440 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.71239241 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71106018 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70026846 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.69934270 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68405189 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.67261458 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66722141 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66595299 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66549734 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65821347 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65814376 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.65778523 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64038890 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63580483 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63546428 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.62789981 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62060635 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61967639 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.61856480 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.59610903 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59543574 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59519572 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59518817 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.58527693 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58435431 |
| 132 | Long-term depression_Homo sapiens_hsa04730 | 0.58310488 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57722767 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.57527233 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57235540 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57211751 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56616081 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56217409 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55593168 |
| 140 | Prostate cancer_Homo sapiens_hsa05215 | 0.54916674 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54879352 |
| 142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54743214 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54588889 |
| 144 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54543461 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54502664 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.49525544 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48747578 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47524001 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47419335 |
| 150 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47355700 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46996788 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.46391973 |
| 153 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45804136 |
| 154 | Taste transduction_Homo sapiens_hsa04742 | 0.45598154 |
| 155 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44382274 |
| 156 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44018063 |
| 157 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42643911 |
| 158 | Melanogenesis_Homo sapiens_hsa04916 | 0.42400268 |
| 159 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38791707 |

